Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 278 No 7448 p446
21 April 2007

This article
Reprint   Photocopy

  Acrobat Reader


News summary


New NICE work programme announced

Clinical guidelines on eight further topics are to be produced by the National Institute for Health and Clinical Excellence.

The 14th wave of referrals to NICE by ministers at the Department of Health seeks guidance for the NHS on:

• Preventing venous thromboembolism in all medical patients admitted to hospitals

• Assessing and managing acute coronary syndromes in adults in primary and secondary care with symptoms of suspected recent onset or deteriorating coronary heart disease

• Investigating, assessing and managing acute chest pain of suspected cardiac origin

• Treating pregnant women who misuse drugs and/or alcohol and the management of their newborn babies

• Managing benign prostatic hyperplasia

• Diagnosing and treating constipation in children

• Recognising and treating neonatal jaundice

• Diagnosing and managing unknown primary tumours

Appraisal review NICE is reviewing the technology appraisal guide that sets out how it takes decisions on the use of new medicines and treatments in the NHS. The review is expected to last until October, after which a draft revised guide will be available for three months of public consultation.

NICE chief executive Andrew Dillon said: “This update will give our stakeholders the chance to tell us how they think our approach should evolve so that we can stay at the leading edge of this important work.”

Back to Top


©The Pharmaceutical Journal